SimSon Laboratories

Hyderabad, India Founded: 2012 • Age: 14 yrs
Delivers RD, analytical testing, and contract manufacturing for pharmaceutical and nutritional industries.

About SimSon Laboratories

SimSon Laboratories is a Healthcare company based in Hyderabad (India) founded in 2012. It delivers RD, analytical testing, and contract manufacturing for pharmaceutical and nutritional industries. It operates on a B2B model. Its Indian entity Simson Life Sciences Private Limited reported revenue of β‚Ή19.23 Cr. Its focus areas include Pharmaceuticals, Research and Development and Analytical Testing. Its competitors include WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus and 4 more; 2 of its 9 listed competitors have raised funding.

Company details

SimSon Laboratories, founded in 2012 in Hyderabad, India, focuses on providing healthcare solutions, producing pharmaceutical products, research and development, and analytical testing. Delivers RD, analytical testing, and contract manufacturing for pharmaceutical and nutritional industries. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

Operational Areas
Key Metrics
  • Annual Revenue
    ₹19.23 Cr

    FY 2025 · +11% YoY

  • Net Profit
    ₹1.94 Cr

    FY 2025 · 10% margin

  • EBITDA
    ₹4.36 Cr

    FY 2025 · 23% margin

Board of directors of Simson Life Sciences Private Limited (SimSon Laboratories)

Simson Life Sciences Private Limited is the primary company behind SimSon Laboratories. The board of Simson Life Sciences Private Limited currently have 2 directors; the longest-serving is Manga Rani Penchala, appointed in 2012.

DirectorDesignationAppointedTenureEntity
Manga Rani Penchala
DIN 05106236
Director13 Jan 201214 yrs 9 moSimson Life Sciences Private Limited
Satyanarayana Rao Penchala
DIN 05106241
Director13 Jan 201214 yrs 9 moSimson Life Sciences Private Limited

Financials of SimSon Laboratories

Figures of Simson Life Sciences Private Limited, the primary company behind SimSon Laboratories, for FY 2025. Revenue was ₹19.23 Cr (+11% year on year). Net profit was ₹1.94 Cr (10% margin). EBITDA was ₹4.36 Cr (23% margin). Revenue has grown at a compounded annual rate of +15% over three years and +13% over five years.

  • ₹19.23 CrRevenue · FY 2025 · +11% YoY
  • ₹1.94 CrNet profit · 10% margin
  • ₹4.36 CrEBITDA · 23% margin
  • ₹1 LakhPaid-up capital
  • +15%Revenue CAGR, 3 years
  • +13%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Simson Life Sciences Private Limited are on its company page.

Premium access

Detailed financial statements for SimSon Laboratories

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of SimSon Laboratories

SimSon Laboratories has 9 listed competitors in our database, 2 of them funded. They include WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
wuxiapptec.com2000Shanghai, China$40M1,681
Provider of CRO and CDMO services
eurofins.com1987Luxembourg––
Laboratory testing and contract research services are provided globally.
ipsen.com1929––505
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
anipharmaceuticals.com1996Baudette, United States–600
Branded and generic prescription drugs are developed, manufactured, and marketed.
rednucleus.com2014Yardley, United States–176
Advisory, scientific, and medical communications provided for pharmaceutical industry.
aptar.com1992Crystal Lake, United States–232
Regulatory support, brand differentiation, and prototyping services are provided.
cheplapharm.com1998Mesekenhagen, Germany–840
Branded pharmaceutical products are developed, marketed, and distributed globally.
aliadatx.com2021Boston, United States$33M–
Provider of drug research & development services for multiple therapeutic areas
cms.net.cn1992Shenzhen, China––
Generic formulations including tablets, capsules, liquids, and injectables are manufactured.
Premium access

Detailed competitors of SimSon Laboratories

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Toxicology

10 companies that operate in the same segment as SimSon Laboratories (Toxicology), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutic solutions for food allergies are developed via antibody platforms.
2019San Francisco, California, United StatesUSD 75 M––
Therapeutics for substance use disorders, including opioid-related conditions, are developed.
2020Oakland, California, United StatesUSD 70 M––
Drug delivery solutions via single-walled carbon nanotubes are offered.
2008Houston, Texas, United StatesUSD 2.5 MUSD 5.07 M9
Non-invasive drug testing technology is developed using fingerprints.
2007Cambridge, Cambridgeshire, United KingdomUSD 25.71 M––
Provides toxicology, chemistry, and consultancy services for agrochemical industries.
2020Vapi, Gujarat, India–––
Instruments for rapid human DNA identification are developed.
2006Pleasanton, California, United StatesUSD 92.06 MUSD 22.5 B78
Oral therapies for snake bite treatment are developed.
2015Corte Madera, California, United StatesUSD 16.48 M––
Quantitative urine drug testing is provided for patient monitoring.
2011San Diego, California, United States––358
Point-of-care platforms for heavy metal toxicity diagnostics are developed.
1968Billerica, Massachusetts, United StatesUSD 34 M––
Real-time trace gas analysis solutions are delivered using SIFT-MS technology.
2002Christchurch, New ZealandUSD 11.9 MUSD 23.52 M–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about SimSon Laboratories

SimSon Laboratories was founded in 2012.

SimSon Laboratories is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

The primary company behind SimSon Laboratories, Simson Life Sciences Private Limited, reported revenue of β‚Ή19.23 Cr for FY 2025, up 11% year on year.

SimSon Laboratories, founded in 2012 in Hyderabad, India, focuses on providing healthcare solutions, producing pharmaceutical products, research and development, and analytical testing. Delivers RD, analytical testing, and contract manufacturing for pharmaceutical and nutritional industries. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

SimSon Laboratories's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.

SimSon Laboratories operates through Simson Life Sciences Private Limited.

The legal entities of SimSon Laboratories currently have 2 directors, including Manga Rani Penchala, Satyanarayana Rao Penchala.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available